The Outline of Prognosis and New Advances in Diagnosis of Oral Squamous Cell Carcinoma (OSCC): Review of the Literature

<table class="table-group" id="tab2"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td align="left">NX</td><td align="left">Regional lymph nodes cannot be assessed</td></tr><tr><td align="left">N0</td><td align="left">No regional lymph node metastasis</td></tr><tr><td align="left">N1</td><td align="left">Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension</td></tr><tr><td align="left">N2 </td><td align="left">Metastasis as specified in N2a, 2b, 2c below</td></tr><tr><td align="left">N2a </td><td align="left">Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension</td></tr><tr><td align="left">N2b</td><td align="left">Metastasis in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension</td></tr><tr><td align="left">N2c </td><td align="left">Metastasis in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension</td></tr><tr><td align="left">N3 </td><td align="left">Metastasis in a lymph node more than 6 cm in greatest dimension</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr><tr class="table-fn"><td>Note: midline nodes are considered ipsilateral nodes.<br/></td></tr></table>

Journal of Oral Oncology

tab2

Table 2

Table 2: The Outline of Prognosis and New Advances in Diagnosis of Oral Squamous Cell Carcinoma (OSCC): Review of the Literature 